Cipla beats estimates with 11 per cent rise in quarterly profit

Read more

Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables

Read more

50 million doses of Covaxin set to expire early 2023

Read more

Pharma industry reports 79 M&A deals in October 2022

Read more

India looking at greater market access for pharma products in UK under proposed FTA: Official

Read more

Hester Bosciences announces results for Q2 and H1 FY23

Read more

Decoding compliance management in pharma sector

Read more

Biological E’s Corbevax safe and immunogenic in five to 18 age group

Read more

Moderna COVID vaccine sales forecasts fall short for 2022, 2023

Read more

The dominance of trade in health

Read more